| |
| |
|
| Insider
Information: |
Kuhlmann Shirley R. |
| Relationship: |
EVP and General Counsel |
| City: |
Canton |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
164,409 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,132,456 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
164,409 |
|
|
| Total
Value |
$6,132,456 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Collegium Pharmaceutical, Inc |
COLL |
EVP and General Counsel |
2024-02-12 |
164,409 |
2018-04-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| COLL |
Collegium Pharmaceutical,... |
EVP and General Counsel |
• – – |
2024-02-12 |
4 |
D |
$33.70 |
$1,070,177 |
D/D |
(31,756) |
164,409 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
EVP and General Counsel |
• – – |
2024-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
76,647 |
196,165 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
EVP and General Counsel |
• – – |
2023-11-27 |
4 |
AS |
$25.78 |
$660,014 |
D/D |
(25,600) |
119,518 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
EVP and General Counsel |
• – – |
2023-11-27 |
4 |
OE |
$15.90 |
$407,040 |
D/D |
25,600 |
145,118 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
EVP and General Counsel |
• – – |
2023-06-26 |
4 |
AS |
$21.65 |
$390,633 |
D/D |
(17,984) |
119,518 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
EVP and General Counsel |
• – – |
2023-02-13 |
4 |
AS |
$26.88 |
$586,280 |
D/D |
(21,811) |
137,502 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
EVP and General Counsel |
• – – |
2023-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
73,864 |
183,359 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
EVP and General Counsel |
• – – |
2023-02-10 |
4 |
D |
$26.75 |
$643,231 |
D/D |
(24,046) |
159,313 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
EVP and General Counsel |
• – – |
2022-09-15 |
4 |
AS |
$18.07 |
$697,303 |
D/D |
(38,589) |
109,495 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
EVP and General Counsel |
• – – |
2022-08-11 |
4 |
AS |
$20.01 |
$6,003 |
D/D |
(300) |
148,084 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
EVP and General Counsel |
• – – |
2022-03-16 |
4 |
D |
$18.99 |
$13,939 |
D/D |
(734) |
148,384 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
EVP and General Counsel |
• – – |
2022-02-10 |
4 |
D |
$17.63 |
$197,086 |
D/D |
(11,179) |
149,118 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
EVP and General Counsel |
• – – |
2022-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
71,041 |
160,297 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
EVP and General Counsel |
• – – |
2021-09-16 |
4 |
D |
$19.67 |
$14,438 |
D/D |
(734) |
89,256 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
EVP and General Counsel |
• – – |
2021-05-10 |
4 |
AS |
$22.77 |
$159,390 |
D/D |
(7,000) |
89,990 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
EVP and General Counsel |
• – – |
2021-03-16 |
4 |
D |
$24.69 |
$18,122 |
D/D |
(734) |
96,990 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
EVP and General Counsel |
• – – |
2021-02-10 |
4 |
D |
$25.95 |
$152,015 |
D/D |
(5,858) |
97,724 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
EVP and General Counsel |
• – – |
2021-01-20 |
4 |
AS |
$24.45 |
$148,680 |
D/D |
(6,081) |
103,582 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
EVP and General Counsel |
• – – |
2021-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
52,132 |
109,663 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
EVP and General Counsel |
• – – |
2020-10-15 |
4 |
AS |
$20.82 |
$146,989 |
D/D |
(7,060) |
57,531 |
0 |
% |
|
| COLL |
Collegium Pharmaceutical,... |
EVP and General Counsel |
• – – |
2020-09-16 |
4 |
D |
$19.33 |
$14,188 |
D/D |
(734) |
64,591 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
EVP and General Counsel |
• – – |
2020-03-16 |
4 |
D |
$15.41 |
$11,311 |
D/D |
(734) |
65,325 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
EVP and General Counsel |
• – – |
2020-02-10 |
4 |
D |
$21.62 |
$45,078 |
D/D |
(2,085) |
66,059 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
EVP and General Counsel |
• – – |
2020-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
24,750 |
68,144 |
0 |
- |
|
| COLL |
Collegium Pharmaceutical,... |
EVP and General Counsel |
• – – |
2019-09-16 |
4 |
D |
$12.44 |
$9,156 |
D/D |
(736) |
43,394 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
